Nimodipine 30 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet/ Injection

Available Strengths: 30 mg

Reference Brands: Nimotop (USA)

Category: Neurology

Nimodipine 30 mg tablets and solution for intravenous infusion, a cerebral-selective calcium channel blocker used in neurocritical care. Listed for hospital pharmacies, importers, distributors and neurosurgical tender buyers.

Product Description:

Nimodipine is a dihydropyridine calcium channel blocker. It is fat-soluble enough to enter the brain and acts preferentially on cerebral arteries, relaxing their smooth muscle by blocking L-type calcium channels. This page covers 30 mg film-coated tablets and nimodipine solution for intravenous infusion. Tablets are the standard route. The infusion is for patients who cannot swallow or absorb tablets, such as ventilated patients in neurocritical care, and runs continuously through a central line with a co-infusion.

Its established use is in aneurysmal subarachnoid haemorrhage, to limit deficits from delayed cerebral ischaemia due to vasospasm. Oral treatment usually starts within four days of the bleed at 60 mg every four hours for 21 days. Hypotension is the main concern, so blood pressure is watched. CYP3A4 breaks it down: grapefruit juice and strong inhibitors raise levels, while rifampicin, carbamazepine and phenytoin cut them sharply. The infusion contains ethanol and binds to PVC, so polyethylene or polypropylene giving sets are used.

Sourcing notes. Both forms are prescription-only hospital medicines, registered nationally in CTD or ACTD format. The pack data show 30 mg for both, but that is the tablet strength; the infusion is normally 0.2 mg/mL, for example 10 mg in 50 mL, so confirm presentation. Nimodipine is light-sensitive, so tablets need opaque blisters and infusion bottles stay in their carton. No refrigeration is needed. Ask for a batch CoA, GMP certificate, CoPP and zone IVb stability. State form, strength, pack size and any PVC-free set needs.